Mindfulness-based Interventions in COPD Patients
SPIROMIND
A Pilot Randomized Controlled Trial to Examine the Feasibility and Effectiveness of a Brief Digital Mindfulness-based Intervention for COPD Patients
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this pilot study is to assess the feasibility of a brief digital mindfulness-based intervention for COPD patients and its effectiveness regarding the reduction of psychological distress as well as stress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2021
CompletedFirst Posted
Study publicly available on registry
February 24, 2021
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2023
CompletedMarch 18, 2024
March 1, 2024
1.7 years
February 11, 2021
March 15, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Psychological distress
Hospital Anxiety and Depression Scale (HADS; Zigmond \& Snaith, 1983; German version Herrmann-Lingen et al., 2011), scores: 0-42, lower scores indicate improvement, interpreting both subscales for anxiety and depression
baseline - 4 weeks
Psychological distress
Hospital Anxiety and Depression Scale (HADS; Zigmond \& Snaith, 1983; German version Herrmann-Lingen et al., 2011), scores: 0-42, lower scores indicate improvement, interpreting both subscales for anxiety and depression
baseline - 8 weeks
Patient's experiences with the digital MBI
patients' experiences assessed in the exit interview (qualitative and quantitative data)
8 weeks
Secondary Outcomes (11)
Chronic stress
baseline, 4 weeks, 8 weeks, 4 months, 6 months
Health related quality of life
baseline, 4 weeks, 8 weeks, 4 months, 6 months
Health status impairment
baseline, 4 weeks, 8 weeks, 4 months, 6 months
Fatigue
baseline, 4 weeks, 8 weeks, 4 months, 6 months
Mindfulness
baseline, 4 weeks, 8 weeks, 4 months, 6 months
- +6 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALParticipants receive a digital mindfulness-based intervention (MBI) + treatment as usual.
Wait list control group
NO INTERVENTIONParticipants receive treatment as usual during the intervention period. They are provided with the digital mindfulness-based intervention (MBI) after the intervention period. The waitlist control group receives the same intervention as the intervention group, with the exception of using not using the exercises via the software on the smartphone, but receiving the exercises as audio files.
Interventions
The digital MBI consists of four auditory guided mindfulness exercises lasting between 10 and 15 minutes. The four exercises are a body scan and three sitting meditations (awareness of the heartbeat, awareness of the body, awareness of sounds). The exercises can be conducted via a software (https://www.movisens.com/de/produkte/movisensxs/) on participants' smartphones. Participants will be familiarized with the concept of mindfulness and the intervention in a single face-to-face introductory session. Additionally, participants will receive a manual, containing all relevant information. Participants will be instructed to practice at least once daily over the course of eight weeks. We recommended to come up with a fixed time point for the mindfulness practice to facilitate a routine. They can choose individually between the exercises. After the intervention period, participants received the exercises as audio files and could continue practicing.
Eligibility Criteria
You may qualify if:
- spirometry confirmed (FEV1\<80%) COPD diagnosis
- psychological distress (as assessed by the Hospital Anxiety and Depression Scale): HADS-A ≥ 8 OR HADS-D ≥ 8 OR\*
- age ≥ 40 years
- ability to understand German
- physical and mental capability to attend the intervention, judged by the treating physician
- life expectancy \> 6 months as judged by treating physician
- ability to use a smartphone
- ability not to smoke for the duration of the measurement time points (2-3 hours) (This criterion has been added later, because we learned that this was a problem for some participants. However, smoking during the measurements heavily affects biomarker data and the subjective stress response to a stress induction protocol.)
You may not qualify if:
- auditory impairment
- any other known severe comorbidities such as heart failure (LVF\<35%), uncontrolled diabetes, concomitant cancer, stroke, unstable coronary heart disease, respiratory failure
- history of/current severe psychological disorder (e.g. schizophrenia, severe cognitive impairment)
- current acute exacerbation of COPD
- any other relevant acute health crisis interfering with the study intervention (e.g. Covid-19)
- receiving any psychosocial treatment (e.g. psychotherapy)
- regular other systematic mind-body-practice
- (\*\*) We further specified this criterion, as we learned that many patients were told to probably have asthma without them knowing exactly if they had an active asthma diagnosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karl Landsteiner Institute for Lung Research and Pneumological Oncologylead
- University of Viennacollaborator
- Klinik Ottakringcollaborator
- Klinik Floridsdorfcollaborator
- Therme Wien Med (Ambulant Pulmonary Rehabilitation)collaborator
Study Sites (1)
Klinik Ottakring
Vienna, 1160, Austria
Related Publications (1)
Tschenett H, Vafai-Tabrizi F, Zwick RH, Valipour A, Funk GC, Nater UM. Digital mindfulness-based intervention for people with COPD - a multicentre pilot and feasibility RCT. Respir Res. 2025 May 26;26(1):199. doi: 10.1186/s12931-025-03243-4.
PMID: 40420253DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.-Prof. Georg-Christian Funk, M.D.
Study Record Dates
First Submitted
February 11, 2021
First Posted
February 24, 2021
Study Start
April 1, 2021
Primary Completion
December 5, 2022
Study Completion
March 27, 2023
Last Updated
March 18, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share